Skip to main content

Advertisement

SpringerLink
Log in

Urticaria: a Multidisciplinary Disease. Where Are We Now?

  • Immunology (HC Lima, Section Editor)
  • Published:
Current Dermatology Reports Aims and scope Submit manuscript

Abstract

Urticaria or hives is a common skin condition, which can have a significant impact on the individual’s quality of life (QOL) and be challenging to treat. Urticaria is divided into acute and chronic, depending on the duration of symptoms. Though urticaria is associated with many different disorders, routine investigations should be limited and guided by history and physical examination. New advances have been made in the classification of chronic urticaria (CU), monitoring of disease activity, QOL, and treatment. An evidence-based approach should be used in the management of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Zuberbier T, Aberer W, Asero C, Bindslev-Jensen C, Brzoza Z, Canonica GW, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria: the 2013 revision and update. Allergy. 2014;69(7):868–87. This article presents the most recent European guidelines regarding urticaria.

    Article  CAS  PubMed  Google Scholar 

  2. Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, Hsieh F, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133(5):1270–7. This article presents the most recent practice parameters from the Joint Task Force on Practice Parameters representing the American Academy of Allergy, Asthma and Immunology and the American College of Allergy Asthma and Immunology.

    Article  PubMed  Google Scholar 

  3. Fonacier LS, Dreskin SC, Leung DYM. Allergic skin diseases. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S138–49.

    Article  PubMed  Google Scholar 

  4. Maurer M, Bindslev-Jensen C, Gimenez-Arnau A, Godse K, Grattan CE, Hide M, et al. Chronic idiopathic urticaria (CIU) is no longer idiopathic: time for an update. Br J Dermatol. 2013;168(2):455–6.

    Article  CAS  PubMed  Google Scholar 

  5. Zuberbier T, Asero R, Bindslev-Jersen C, Canonica GW, Church MK, Gimenez-Arnau AM, et al. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009;64:1417–26.

    Article  CAS  PubMed  Google Scholar 

  6. Maurer M, Weller K, Bindslev-Jensen C, Gimenez-Arnau A, Bousquet PJ, Bousquet J, et al. Unmet clinical needs in chronic urticaria. A GA2LEN task force report. Allergy. 2011;66:317–30.

    Article  CAS  PubMed  Google Scholar 

  7. Gaig P, Olona M, Munoz Lejarazu D, Cabellero M, Dominguez F, Echechipia S, et al. Epidemiology of chronic urticaria in Spain. J Investig Allergol Clin Immunol. 2004;14:214–20.

    CAS  PubMed  Google Scholar 

  8. Viegas LP, Ferreira MB, Kaplan AP. The maddening itch: an approach to chronic urticaria. J Invest Allergol Clin Immunol. 2014;24(1):1–5.

    CAS  Google Scholar 

  9. Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol. 1989;84(1):66–71.

    Article  CAS  PubMed  Google Scholar 

  10. Grattan CE, O’Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT, et al. Randomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticaria. Br J Dermatol. 2000;143(2):365–72.

    Article  CAS  PubMed  Google Scholar 

  11. Vonakis BM, Vasagar K, Gibbons Jr SP, Gober L, Sterba PM, Chang H, et al. Basophil FcεRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria. J Allergy Clin Immunol. 2007;119(2):441–8.

    Article  CAS  PubMed  Google Scholar 

  12. Ben-Shoshan M, Blinerman I, Raz A. Psychosocial factors and chronic spontaneous urticaria: a systematic review. Allergy. 2013;68(2):131–41.

    Article  CAS  PubMed  Google Scholar 

  13. Kozel MM, Bossuyt PM, Mekkes JR, Bos JD. Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic review. J Am Acad Dermatol. 2003;48:409–16.

    Article  PubMed  Google Scholar 

  14. Sabroe RA, Fiebiger E, Francis DM, Maurer D, Seed PT, Grattan CE, et al. Classification of anti-Fc epsilon RI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol. 2002;110:492–9.

    Article  CAS  PubMed  Google Scholar 

  15. Konstantinou GN, Asero R, Ferrer M, Knol EF, Maurer M, Raap U, et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy. 2013;68:27–36.

    Article  CAS  PubMed  Google Scholar 

  16. Mlynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria. Allergy. 2008;63:777–80.

    Article  CAS  PubMed  Google Scholar 

  17. Staevska M, Popov TA, Kralimarkova T, Lazarova C, Kraeva S, Popova D, et al. Effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult to treat urticaria. J Allergy Clin Immunol. 2010;125(3):676–82.

    Article  CAS  PubMed  Google Scholar 

  18. Grob JJ, Auquier P, Dreyfus I, Ortonne P. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life. Allergy. 2009;64:605–12.

    Article  CAS  PubMed  Google Scholar 

  19. Zuberbier T, Asero R, Bindslev-Jersen C, Canonica GW, Church MK, Gimenez-Arnau AM, et al. EAACI/GA2LEN/EDF/WAO guideline: management of urticaria. Allergy. 2009;64:1427–43.

    Article  CAS  PubMed  Google Scholar 

  20. Church MK, Maurer M, Simons FE, Bindslev-Jensen C, van Cauwenberge P, Bousquet J, et al. Risk of first-generation H(1)-antihistamines: a GA2LEN position paper. Allergy. 2010;65(4):459–66.

    Article  CAS  PubMed  Google Scholar 

  21. Staevska M, Gugutkova M, Lazarova C, Kralimarkova T, Dimitrov V, Zuberbier T, et al. Night-time sedating H1-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. Br J Dermatol. 2014;171(1):148–54.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. de Silva NL, Damayanthi H, Chamarie R, Rodrigo C, Rajapakse S. Leukotriene receptor antagonists for chronic urticaria: a systematic review. Allergy Asthma Clin Immunol. 2014;10(1):24.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Vena GA, Cassano N, Colombo D, Peruzzi E, Pigatto P, Neo O-30 Study Group. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol. 2006;55(4):705–9.

    Article  PubMed  Google Scholar 

  24. Maurer M, Rosen K, Hsieh HJ, Saini S, Gratten C, Gimenez-Arnau A, et al. Omalizumab for the treatment of chronic spontaneous urticaria. N Engl J Med. 2013;368:924–35. This study examined the efficacy and safety of anti-IgE therapy in the treatment of chronic spontaneous urticaria.

    Article  CAS  PubMed  Google Scholar 

  25. Kaplan A, Ledford D, Ashby M, Canvin J, Zazzali JL, Conner E, et al. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013;132(1):101–9. This study compared anti-IgE therapy in the treatment of chronic urticaria in those not adequately managed on standard combination therapy.

    Article  CAS  PubMed  Google Scholar 

  26. Hannuksela M, Kokkonen EL. Ultraviolet light therapy in chronic urticaria. Acta Derm Venereol. 1985;65(5):449–50.

    CAS  PubMed  Google Scholar 

  27. O’Donnell BF, Barr RM, Black AK, Francis DM, Kermani F, Niimi N, et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol. 1998;138(1):101–6.

    Article  PubMed  Google Scholar 

  28. Baiardini I, Pasquali M, Braido F, Fumagalli F, Guerra L, Compalati E, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy. 2005;60:1073–8.

    Article  CAS  PubMed  Google Scholar 

  29. Weller K, Groffik A, Magerl M, Tohme N, Martus P, Rause K, et al. Development, validation and internal results of the angioedema activity score. Allergy. 2013;68:1185–92.

    CAS  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

J Quirt and H Lima both declare no conflicts of interest.

S Waserman has received honoraria and participates in advisory boards for GSK, Takeda, CSL Behring, Shire, Merck, Health Canada, Paladin Labs, Sanofi Canada, and Pfizer Canada.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Division of Clinical Immunology and Allergy, McMaster University, HSC-3W11, 1280 Main St. West, Hamilton, ON, L8S 4K1, Canada

    Jaclyn Quirt

  2. Division of Dermatology, Department of Medicine, McMaster University, HSC-3U8, 1280 Main St. West, Hamilton, ON, L8S 4K1, Canada

    Hermenio Lima

  3. Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, HSC-3V49, 1280 Main St. West, Hamilton, ON, L8S 4K1, Canada

    Susan Waserman

Authors
  1. Jaclyn Quirt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hermenio Lima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susan Waserman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaclyn Quirt.

Additional information

This article is part of the Topical Collection on Immunology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Quirt, J., Lima, H. & Waserman, S. Urticaria: a Multidisciplinary Disease. Where Are We Now?. Curr Derm Rep 4, 8–14 (2015). https://doi.org/10.1007/s13671-014-0095-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13671-014-0095-9

Keywords

Search

Navigation